勘误：1757. 使用治疗结果期望排序法管理抗菌治疗（DOOR-MAT）评估由大肠埃希菌和肺炎克雷伯菌引起的血流感染（BSI）中快速分子诊断（RMD）指导的抗生素治疗
Corrigendum to: 1757. Using the Desirability of Outcome Ranking for Management of Antimicrobial Therapy (DOOR-MAT) to Assess Antibiotic Therapy Guided by Rapid Molecular Diagnostics (RMD) in Bloodstream Infection (BSI) Caused by Escherichia coli and Klebsiella pneumonia.
作者信息
Wilson Brigid, Viau Roberto, Perez Federico, Jiang Hongyu, Fowler Vance G, Chambers Henry F, Kreiswirth Barry N, Bonomo Robert A, Evans Scott R
出版信息
Open Forum Infect Dis. 2019 Jul 3;6(7):ofz267. doi: 10.1093/ofid/ofz267. eCollection 2019 Jul.
Abstract
[This corrects the article DOI: 10.1093/ofid/ofy209.142.].
摘要
[这更正了文章的数字对象标识符：10.1093/ofid/ofy209.142。]
相似文献
1
Corrigendum to: 1757. Using the Desirability of Outcome Ranking for Management of Antimicrobial Therapy (DOOR-MAT) to Assess Antibiotic Therapy Guided by Rapid Molecular Diagnostics (RMD) in Bloodstream Infection (BSI) Caused by Escherichia coli and Klebsiella pneumonia.勘误：1757. 使用治疗结果期望排序法管理抗菌治疗（DOOR-MAT）评估由大肠埃希菌和肺炎克雷伯菌引起的血流感染（BSI）中快速分子诊断（RMD）指导的抗生素治疗
Open Forum Infect Dis. 2019 Jul 3;6(7):ofz267. doi: 10.1093/ofid/ofz267. eCollection 2019 Jul.
2
Comparing the Clinical Utility of Rapid Diagnostics for Treatment of Bloodstream Infections Using Desirability of Outcome Ranking Approach for the Management of Antibiotic Therapy (DOOR-MAT).使用管理抗生素治疗的结果偏好排序方法（DOOR-MAT）比较快速诊断在治疗血流感染中的临床实用性。
Antimicrob Agents Chemother. 2021 Aug 17;65(9):e0044121. doi: 10.1128/AAC.00441-21.
3
Desirability of Outcome Ranking for the Management of Antimicrobial Therapy (DOOR MAT): A Framework for Assessing Antibiotic Selection Strategies in the Presence of Drug Resistance.治疗抗菌药物管理中结果排序的可取性 (DOOR MAT)：在存在药物耐药性的情况下评估抗生素选择策略的框架。
Clin Infect Dis. 2021 Jul 15;73(2):344-350. doi: 10.1093/cid/ciaa1769.
4
Risk factors for bloodstream infection caused by extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae: A focus on antimicrobials including cefepime.产超广谱β-内酰胺酶大肠埃希菌和肺炎克雷伯菌所致血流感染的危险因素：重点关注包括头孢吡肟在内的抗菌药物。
Am J Infect Control. 2015 Jul 1;43(7):719-23. doi: 10.1016/j.ajic.2015.02.030. Epub 2015 Apr 29.
5
Good Studies Evaluate the Disease While Great Studies Evaluate the Patient: Development and Application of a Desirability of Outcome Ranking Endpoint for Staphylococcus aureus Bloodstream Infection.好的研究评估疾病，而伟大的研究评估患者：金黄色葡萄球菌血流感染结局期望评分终点的制定和应用。
Clin Infect Dis. 2019 May 2;68(10):1691-1698. doi: 10.1093/cid/ciy766.
6
Enteric gram-negative bacilli bloodstream infections: 17 years' experience in a neonatal intensive care unit.肠道革兰氏阴性杆菌血流感染：新生儿重症监护病房17年的经验
Am J Infect Control. 2004 Jun;32(4):189-95. doi: 10.1016/j.ajic.2003.07.004.
7
Integrating rapid diagnostics and antimicrobial stewardship improves outcomes in patients with antibiotic-resistant Gram-negative bacteremia.快速诊断与抗菌药物管理的整合可改善抗生素耐药革兰氏阴性菌血症患者的结局。
J Infect. 2014 Sep;69(3):216-25. doi: 10.1016/j.jinf.2014.05.005. Epub 2014 May 17.
8
Trends in antimicrobial resistance and empiric antibiotic therapy of bloodstream infections at a general hospital in Mid-Norway: a prospective observational study.挪威中部一家综合医院血流感染的抗菌药物耐药性及经验性抗生素治疗趋势：一项前瞻性观察研究。
BMC Infect Dis. 2017 Feb 2;17(1):116. doi: 10.1186/s12879-017-2210-6.
9
Evaluation of risk factors for the acquisition of bloodstream infections with extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species in the intensive care unit; antibiotic management and clinical outcome.重症监护病房中产超广谱β-内酰胺酶大肠埃希菌和克雷伯菌属血流感染危险因素的评估；抗生素管理及临床结局
J Hosp Infect. 2008 Feb;68(2):108-15. doi: 10.1016/j.jhin.2007.10.011. Epub 2007 Dec 11.
10
Desirability of outcome ranking and quality life measurement for antimicrobial research in organ transplantation.器官移植中抗菌药物研究的结果排序和生活质量测量的可取性。
Transpl Infect Dis. 2022 Oct;24(5):e13888. doi: 10.1111/tid.13888.
引用本文的文献
1
Comparing the Clinical Utility of Rapid Diagnostics for Treatment of Bloodstream Infections Using Desirability of Outcome Ranking Approach for the Management of Antibiotic Therapy (DOOR-MAT).使用管理抗生素治疗的结果偏好排序方法（DOOR-MAT）比较快速诊断在治疗血流感染中的临床实用性。
Antimicrob Agents Chemother. 2021 Aug 17;65(9):e0044121. doi: 10.1128/AAC.00441-21.
2
Day at the Races: Comparing BioFire FilmArray Blood Culture ID Panels With Verigene Blood Culture Panel in Gram-Negative Bloodstream Infections Using DOOR-MAT Analysis.赛马日：使用 DOOR-MAT 分析比较生物梅里埃 FilmArray 血培养 ID 检测板与 Verigene 血培养 panel 在革兰氏阴性菌血流感染中的应用。
Clin Infect Dis. 2021 Sep 15;73(6):1103-1106. doi: 10.1093/cid/ciab262.
Zotero 插件